When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMRX - Impax Labs pay-for-delay deal for generic Opana ER illegal - FTC
Amneal Pharmaceuticals Inc. Class A
In a unanimous vote, the U.S. Federal Trade Commission (FTC) rules that Impax Laboratories LLC (NYSE:AMRX) entered into an illegal pay-for-delay scheme with Endo Pharmaceuticals (NASDAQ:ENDP) aimed at keeping the former's generic version of opioid pain med Opana ER (oxymorphone hydrochloride) extended-release tablets off the market.
More news on: Amneal Pharmaceuticals, Inc., Endo International plc, Healthcare stocks news,